Maria Isabel Lovo Martins Selected Research

N- acetylcysteine- 1- (4- chlorobenzoyl)- 5- methoxy- 2- methyl- 1H- indole- 3- acetic acid 4-(nitrooxy)butyl ester

2/2015

Nitric oxide-releasing indomethacin enhances susceptibility to Trypanosoma cruzi infection acting in the cell invasion and oxidative stress associated with anemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Isabel Lovo Martins Research Topics

Disease

1	Neoplasms (Cancer) 07/2017
1	Weight Loss (Weight Reduction) 07/2017
1	Cachexia 07/2017
1	Parasitemia 02/2015
1	Anemia 02/2015
1	Infections 02/2015
1	Chagas Disease (American Trypanosomiasis) 02/2015

Drug/Important Bio-Agent (IBA)

1	Lipase (Acid Lipase)FDA Link 07/2017
1	DipeptidesIBA 07/2017
1	Glutamine (L-Glutamine)FDA Link 07/2017
1	Guanosine Diphosphate (GDP)IBA 07/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2017
1	Interleukin-6 (Interleukin 6)IBA 07/2017
1	Sterol Esterase (Hormone-Sensitive Lipase)IBA 07/2017
1	Insulin (Novolin)FDA Link 07/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2015
1	Indomethacin (Indometacin)FDA LinkGeneric 02/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2015
1	N- acetylcysteine- 1- (4- chlorobenzoyl)- 5- methoxy- 2- methyl- 1H- indole- 3- acetic acid 4-(nitrooxy)butyl esterIBA 02/2015

Therapy/Procedure

1	Therapeutics 02/2015